These findings provided a molecular mechanism of SEMA3G on ccRCC metastasis and EMT, which supported theoretical establishment of SEMA3G as a modulator and facilitates precision treatment of ccRCC. Here, SEMA3G is linked to nonpapillary renal cell carcinoma.